Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 36,068,736	$ 564,124
Restricted cash	50,000
Deferred offering costs		121,712
Prepaid expenses and other current assets	3,562,822	78,057
Total current assets	39,681,558	763,893
Non-current assets:
Property and equipment, net	655,783	458,591
Right-of-use asset	391,519
Goodwill	29,367,213
Total assets	70,096,073	1,222,484
Current liabilities:
Accounts payable	2,649,602	715,653
Accrued expenses	995,588	2,634,790
Short-term debt	1,297,777
Right-of-use liability, current	24,727
Total current liabilities	4,967,694	3,350,443
Non-current liabilities:
Right-of-use liability, long-term	386,538
Total liabilities	5,354,232	3,350,443
Commitments and Contingencies (Note 6)
Stockholders' Equity (Deficit)
Preferred Stock, $0.001 par value, authorized 10,000,000 shares: Series 1 Convertible Preferred Stock, 3,880 and 0 shares authorized at March 31, 2020 and December 31, 2019, respectively, 3,879 and 0 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively.	4
Common Stock, $0.001 par value, authorized 100,000,000 shares: Common Stock, 5,843,203 and 2,627,533 common shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively.	5,843	2,628
Additional Paid in Capital	87,577,911	10,651,073
Accumulated Deficit	(22,841,917)	(12,781,660)
Total Stockholders' Equity (Deficit)	64,741,841	(2,127,959)
Total Liabilities and Stockholders' Equity (Deficit)	$ 70,096,073	$ 1,222,484